Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Vissing

Showing results (71-80 of 416) with videos related to

Pageof 42
Sort By:
Cells|April 3, 2021
Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited SuccessTue L Nielsen, John Vissing, Thomas O Krag
Clinical Neurology and Neurosurgery|January 28, 2015
Clinical and neurophysiological response to pharmacological treatment of DOK7 congenital myasthenia in an older patientNanna Witting, Clarissa Crone, Morten Duno, et al.
European Journal of Human Genetics : EJHG|December 24, 2025
A homozygous variant in the beta-1,3-N-acetylglucosaminyltransferase 4 gene causes progressive brain atrophy and muscular dystrophyJohn Vissing, Ana Töpf, Volker Straub, et al.
European Journal of Neurology|March 25, 2024
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravisAndreas Meisel, Francesco Saccà, Jennifer Spillane, et al.
Scientific Reports|May 1, 2020
A quantitative method to assess muscle edema using short TI inversion recovery MRIJulia R Dahlqvist, Ruth Salim, Carsten Thomsen, et al.
Journal of Neurology|May 5, 2017
High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trialGrete Andersen, Karen Heje, Astrid Emile Buch, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Physical training for McArdle diseaseRosaline Quinlivan, John Vissing, David Hilton-Jones, et al.
Mitochondrion|November 19, 2016
Dysphagia is prevalent in patients with CPEO and single, large-scale deletions in mtDNAGitte Hedermann, Nicoline Løkken, Julia R Dahlqvist, et al.
Frontiers in Neurology|January 20, 2021
Quantitative Muscle MRI as Outcome Measure in Patients With Becker Muscular Dystrophy-A 1-Year Follow-Up StudyAisha M Sheikh, Karen Rudolf, Nanna Witting, et al.
Muscle & Nerve|July 23, 2024
Diagnostic workup of rhabdomyolysis: Genetic testing should precede neurophysiological testingNicol C Voermans, Salman Bhai, Pascal Laforet, et al.
Pageof 42

Showing results (71-80 of 416) with videos related to

Sort By:
Pageof 42
Cells|April 3, 2021
Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited SuccessTue L Nielsen, John Vissing, Thomas O Krag
Clinical Neurology and Neurosurgery|January 28, 2015
Clinical and neurophysiological response to pharmacological treatment of DOK7 congenital myasthenia in an older patientNanna Witting, Clarissa Crone, Morten Duno, et al.
European Journal of Human Genetics : EJHG|December 24, 2025
A homozygous variant in the beta-1,3-N-acetylglucosaminyltransferase 4 gene causes progressive brain atrophy and muscular dystrophyJohn Vissing, Ana Töpf, Volker Straub, et al.
European Journal of Neurology|March 25, 2024
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravisAndreas Meisel, Francesco Saccà, Jennifer Spillane, et al.
Scientific Reports|May 1, 2020
A quantitative method to assess muscle edema using short TI inversion recovery MRIJulia R Dahlqvist, Ruth Salim, Carsten Thomsen, et al.
Journal of Neurology|May 5, 2017
High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trialGrete Andersen, Karen Heje, Astrid Emile Buch, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Physical training for McArdle diseaseRosaline Quinlivan, John Vissing, David Hilton-Jones, et al.
Mitochondrion|November 19, 2016
Dysphagia is prevalent in patients with CPEO and single, large-scale deletions in mtDNAGitte Hedermann, Nicoline Løkken, Julia R Dahlqvist, et al.
Frontiers in Neurology|January 20, 2021
Quantitative Muscle MRI as Outcome Measure in Patients With Becker Muscular Dystrophy-A 1-Year Follow-Up StudyAisha M Sheikh, Karen Rudolf, Nanna Witting, et al.
Muscle & Nerve|July 23, 2024
Diagnostic workup of rhabdomyolysis: Genetic testing should precede neurophysiological testingNicol C Voermans, Salman Bhai, Pascal Laforet, et al.
Pageof 42